logo
Britons smoke nearly 30 billion cigarettes every year, study finds

Britons smoke nearly 30 billion cigarettes every year, study finds

Independent17-07-2025
An estimated 28.6 billion cigarettes are smoked in Britain each year, equating to 78 million every day, according to a new analysis that highlights stark inequalities in consumption across the country. Researchers are now calling for targeted public health efforts to address these disparities and tackle persistent smoking rates.
Charities have branded the "staggering figure" a "stark reminder of the deadly toll of inaction", urging the Government to prioritise the Tobacco and Vapes Bill once Parliament reconvenes after its summer recess.
The study, conducted by Cancer Research UK in collaboration with experts at University College London (UCL), drew on monthly data from the Smoking Toolkit Study between 2022 and 2024. It estimates that adults who smoke consume an average of 10.4 cigarettes daily, with 5.5 per cent of smokers exceeding 20 cigarettes a day. This translates to an average of 528 cigarettes per smoker annually, culminating in the 28.6 billion figure for Great Britain.
While Office for National Statistics (ONS) data indicates that 11.9 per cent of UK adults – approximately six million people – smoked in 2023, marking the lowest proportion since records began in 2011, England faces a significant challenge. Cancer Research UK warns that the nation could struggle to meet its smokefree target of 5 per cent by 2030, with projections suggesting this goal may not be achieved until 2039 if current trends persist.
The analysis also underscored significant inequalities in cigarette consumption. Individuals from more deprived backgrounds smoked an average of 11 cigarettes daily, compared to 9.4 per day among those in wealthier areas. Regionally, the North East and Scotland recorded the highest consumption, with 11.7 cigarettes each per day, while London and the South West reported the lowest, at 8.4 and 9.5 cigarettes respectively.
Dr Sarah Jackson, a research fellow at UCL's Institute of Epidemiology and Health Care, emphasised the dual benefits of reducing consumption. "Tackling smoking is not just about preventing uptake among future generations," she stated. "Supporting the six million people in the UK who currently smoke cigarettes to quit will have major benefits for public health and for the environment." Dr Jackson highlighted that despite declining rates, over 28 billion cigarettes are still consumed annually, generating "up to 140,000 metric tons of toxic, non-biodegradable waste". She added: "Reducing cigarette consumption, particularly in the most affected regions and communities, is critical not only to save lives and narrow health inequalities, but also to protect our environment from one of the most pervasive forms of plastic pollution."
Dr Ian Walker, executive director of policy at Cancer Research UK, stressed the need for continued vigilance. "While great strides have been made to bring down smoking rates, we can't afford to be complacent," he said. "Every week, around 550 million cigarettes are still smoked in Britain – that's enough to fill an Olympic sized swimming pool. It's vital that everyone, wherever they live, can access the support they need to quit smoking for good."
Dr Walker described the Tobacco and Vapes Bill as "a historic opportunity to help stub out the harms of smoking" but expressed frustration that the legislation "isn't progressing through Parliament as quickly as it should be". The bill, which cleared the House of Commons in March, aims to prevent anyone born on or after January 1, 2009, from legally smoking if it becomes law. It is currently awaiting further scrutiny in the House of Lords.
However, the analysis reveals that approximately 20 billion cigarettes have been smoked in Britain since the bill was reintroduced in the Commons last November. Dr Walker urged: "Tobacco is a toxic product that should have no place in our future, and I urge all parliamentarians to back a smokefree UK and prioritise this Bill when it returns to the House of Lords. This world-leading legislation has strong political and public support that can't be ignored."
Reacting to the study, Hazel Cheeseman, chief executive of Action on Smoking and Health (Ash), underscored the urgency. "Since Parliament last debated the Tobacco and Vapes Bill, an estimated 6.7 billion cigarettes have been smoked in the UK," she said. "That staggering figure is a stark reminder of the deadly toll of inaction. Every day that passes without this legislation is a day lost in protecting our children from addiction and improving public health. We urge the Government to make this Bill a priority immediately after summer recess. The country cannot afford further delay – this is a once-in-a-generation opportunity to create a smokefree future, and it must not be squandered."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UK-India trade deal sparks fears over access to cheap medicines for millions
UK-India trade deal sparks fears over access to cheap medicines for millions

ITV News

time12 minutes ago

  • ITV News

UK-India trade deal sparks fears over access to cheap medicines for millions

A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...

Health warning over counterfeit vodka made with medical-grade alcohol
Health warning over counterfeit vodka made with medical-grade alcohol

Metro

time42 minutes ago

  • Metro

Health warning over counterfeit vodka made with medical-grade alcohol

Health officials in Scotland have warned fans of Glen's vodka to keep an eye out for fake half bottles containing medical disinfectant. Scammers have hijacked the popular brand to sell counterfeit products containing the chemical isopropyl, which is typically used in hospital settings or in hand sanitiser. Food Standards Scotland (FSS) say the fake booze will smell and taste 'very different' to the Glen's product people recognise. Even small amounts of isopropyl can result in abdominal pain, vomiting, dizziness and headaches, they warned. Severe cases can leave drinkers in a coma or even dead. Genuine bottles of Glen's have a laser-etched code between the rear label and the base of the bottle which the fake bottles will not. More Trending Anyone concerned they might have drunk the counterfeit vodka, and who is experiencing symptoms, is urged to contact NHS 24 on 111 immediately. Glen's, one of the cheaper brands of vodka on the market, is a popular target for scammers. FSS has previously sent investigators to seize dozens of bottles of fake spirit using the same label from a shop in Coatbridge, Lanarkshire. And in September last year, the UK-wide Food Standards Agency sent out a warning about another fraud involving isopropyl alcohol in Glen's bottles. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: The one drink you should never order from a restaurant wine list MORE: How a generation-bending TikTok campaign saved a local boozer MORE: Forget about Prosecco — drink this £6.97 sparkling wine from Asda instead

NHS: Strike-hit appointments to be rebooked in two weeks but will impact others
NHS: Strike-hit appointments to be rebooked in two weeks but will impact others

The Independent

time42 minutes ago

  • The Independent

NHS: Strike-hit appointments to be rebooked in two weeks but will impact others

NHS England has said hospitals are aiming to reschedule appointments cancelled due to strikes within two weeks, but warned of knock-on impacts for other patients. Professor Meghana Pandit, NHS England's co-national medical director (secondary care), said that despite the five-day walkout by thousands of resident doctors in England, which began on Friday, local trusts have managed to maintain services with 'minimal disruption'. She told BBC Breakfast: 'If there's any rescheduling or postponement of surgery or appointments then the hospitals try their upmost best to get that appointment rescheduled within two weeks. 'I know it is distressing and even two weeks is too long for somebody to wait and actually that has an impact on the people who who are then displaced at that two week period.' Prof Pandit said there were three 'derogations' granted on Friday, a process which allows hospitals to request striking doctors return to work if there is a risk to patient safety. Nottingham City Hospital reached an agreement with the British Medical Association (BMA) to exempt one doctor from the strike to work on the neonatal intensive care unit. A derogation was agreed for one doctor in the emergency department and another doctor in the ISGM at the Northern General Hospital. The BMA said it had also agreed a derogation for two anaesthetists to work at University Hospital Lewisham on Saturday to ensure patient safety. It comes as Wes Streeting said 'we are doing everything we can to minimise' patient harm. The Health Secretary condemned the strike as 'reckless' and said the Government would not allow the BMA to 'hold the country to ransom'. Sir Keir Starmer made a last-minute appeal to resident doctors, saying the strikes would 'cause real damage'. He added: 'Most people do not support these strikes. They know they will cause real damage… 'These strikes threaten to turn back the clock on progress we have made in rebuilding the NHS over the last year, choking off the recovery.' The BMA has argued that real-terms pay has fallen by around 20% since 2008, and is pushing for full 'pay restoration'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store